Takashi Eguchi

Visiting Investigator

Email

eguchit@mskcc.org

Start Year

2014

Scholarships

Shinshu University Research Scholarship Research Scholarship

Publications

Manuscripts

Abstracts/Presentations

  • Adusumilli P, Bueno R, Cerfolio R, Harpole Jr. D, Eguchi T, Lu S, Gustafson C, Calloway S, Joshi MB, Evans B, Hughes E, Yager K, Sibley A, Jones JT, Hartman AR. Elevated Expression of Cell Cycle Progression Genes is Associated with Absolute Chemotherapy Benefit in Early Stage Lung Adenocarcinoma Patients. 2016 American Society of Clinical Oncology Annual Meeting. June 3-7, 2016; Chicago, Illinois.
  • Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Adusumilli P, Travis W. Spread Through Air Spaces (STAS) is an Independent Predictor of Recurrence in Lung Squamous Cell Carcinoma. 2016 United States & Canadian Academy of Pathology Annual Meeting. March 12-18, 2016; Seattle, WA.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Rizk NP, Woo KM, Sima CS, Park BJ, Jones DR, Travis WD, Adusumilli PS. T1a Lung Adenocarcinomas: Presence of Spread of Tumor through Alveolar Spaces (STAS), Micropapillary and Solid Patterns Determines Outcomes International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Buitrago DH, Mayor M, Kadota K, Rizk NP, Park BJ, Jones DR, Adusumilli PS. Long and Short-Term Predictors of Outcome in Elderly Patients (≥ 75 Years) Undergoing Lobectomy for Stage I Non-Small Cell Lung Cancer. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Leduc C, Rekhtman N, Moreira A, Jones DR, Adusumilli PS. HNF4α Is a Marker for Invasive Mucinous Adenocarcinoma (IMA) and a Prognostic Factor in Stage I Lung Adenocarcinoma (LADC). International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Ujiie H, Eguchi T, Mayor M, Kadota K, Travis WD, Jones DR, Sadelain M, Adusumilli PS. Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Adusumilli PS, Eguchi T. Validation of a cell cycle progression score for 5-year mortality risk in patients with stage I non-small cell lung cancer. 2015 American Society of Clinical Oncology Annual Meeting. May 29-June 2, 2015; Chicago, IL.
  • Chauhan C, Buitrago D, Eguchi T, Adusumilli PS. Comorbidities and cancer-specific outcomes in younger and elderly patients following resection for Stage I non-small cell lung cancer. 37th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 8, 2014; New York, NY.